Option chain shows key data for SINTX Technologies's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for SINTX Technologies.

SINTX Technologies (NASDAQ:SINT) Stock, Option Chain

SINTX Technologies

SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.

SINTX Techs

doctor-563429

News

SINT

SINTX Technologies shares are trading lower by 23% during Wednesday&#39;s session. The company announced a $5 million private placement.

Why SINTX Technologies Stock Is Down 21%

S&P 500

Earnings

Equities

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

ALUR

CNSP

COMP

NKLA

SEDG

S&amp;P 500 Edges Higher; Analog Devices Earnings Top Views

5 Stocks To Watch Heading Into Thursday

AUUD

OSRH

Dow Dips 150 Points; US Housing Starts Fall In January

SINTX Technologies Inc

SINTX Technologies Inc Warrants (14/05/2023)

Sintana Energy Inc

Sintana Energy Inc Warrants (08/03/2024)

Sintokogio Ltd

Press Releases

SINTX Technologies and NED Medical Partner to Advance Cutting-Edge Ceramic Microsphere Medical Devices for Cancer Treatment

SINTX Technologies Secures Patent Allowance for Wide-Ranging Silicon Nitride Biomaterial Applications

SINTX Receives Issuance of U.S. Patent for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

"Technology Stocks to Watch: CSDX, LYT, SINT, TRNR, RSLS, CYCU, TRUG Market Momentum Building"

UroGen Pharma Ltd. (NASDAQ: URGN), CS Diagnostics Corp. (OTCQB: CSDX) and Boston Scientific (NYSE: BSX) Advancing Cancer Treatment Technology – More Stocks Inside

SINTX Technologies Sells Technology Assesment and Transfer Subsidiary to Focus on Medical Device Market

SINTX Technologies Announces $5 Million Private Placement Priced At-the-Market under Nasdaq Rules

Sintx Technologies Announces Board Chairman Transition

SINTX Technologies Announces Publication of Study Confirming Superior Performance of Silicon Nitride in Cervical Spine Fusion

SINTX Technologies Announces Strategic Changes to Board of Directors

CSDX

CYCU

IQST

RSLS

TRNR

TRUG

URGN

Aethlon Medical

Autonomix Medical

Accelerate Diagnostics, Inc. - Common Stock

Accelerate Diagnostics

Bluejay Diagnostics

Biomerica

Co-Diagnostics

DIH Holding US, Inc. - Class A Common Stock

DIH Holding US

Ekso Bionics Holdings, Inc. - Common Stock

Ekso Bionics Holdings

GlucoTrack

HeartSciences

Helius Medical Technologies, Inc. - Class A Common Stock

Helius Medical Tech

SeaStar Medical Holding Corporation - Common Stock

SeaStar Medical Holding

Intelligent Bio Solutions Inc. - Common Stock

Intelligent Bio Solutions

INVO Fertility

NanoVibronix

ENDRA Life Sciences

Nuwellis

Predictive Oncology

ReShape Lifesciences, Inc. - Common Stock

Reshape Lifesciences

Strata Skin Sciences, Inc. - Common Stock

Strata Skin Sciences

Tivic Health Systems, Inc. - Common stock

Tivic Health Systems

Tenon Medical

Venus Concept

Catheter Precision

Xylo Technologies Ltd. - American Depositary Shares

Xylo Technologies

Ascendiant Capital

Comments

SINTX Technologies

SINTX Technologies (SINT) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell